19 Tips for Finding...
Health Care: Drugs
Dynavax Technologies Corporation (DVAX: NASDAQ)
$3.56 -0.05 | -1.38%
06/04/12 - 09:45 AM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 28.50 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | 189.00 | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | 18.60 | 12.50 |
| Beta | 2.88 | 0.62 | 0.98 |
| Price to Sales (TTM) | 25.45 | 4.29 | 1.42 |
| Price to Book (MRQ) | 6.40 | 4.39 | 2.41 |
| Price to Tangible Book (MRQ) | 6.59 | 14.20 | 5.08 |
| Price to Cash Flow (TTM) | -12.90 | 19.50 | 9.80 |
| Price to Free Cash Flow (TTM) | -15.00 | -327.00 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.90 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.80 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | 42.32 | -0.76 |
| Payout Ratio (TTM) | 0.00 | 51.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | 34.70 | 15.60 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | -9.80 | 9.00 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | 18.20 | 6.32 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | -2.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | -2.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | 24.63 | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | -46.36 | -6.43 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 4.20 | 1.30 | 1.10 |
| Current Ratio (MRQ) | 4.30 | 1.80 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.29 | 0.82 |
| Total Debt to Equity (MRQ) | 0.15 | 0.37 | 0.96 |
| Interest Coverage (TTM) | n.a. | 9.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | n.a. | 75.60 | 46.90 |
| Gross Margin - 5 Yr Avg | n.a. | 75.30 | 47.70 |
| EBITD Margin (TTM) | n.a. | 29.40 | 18.90 |
| EBITD - 5 Yr Avg | -184.89 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | n.a. | 18.00 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | n.a. | 11.80 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | -2.10 | 0.14 | 0.09 |
| Net Profit Margin - 5 Yr Avg | n.a. | 8.60 | 7.00 |
| Return on Assets (TTM) | -38.60 | 7.30 | 3.10 |
| Return on Assets - 5 Yr Avg | -45.30 | 4.60 | 2.50 |
| Return on Investment (TTM) | -52.00 | 10.40 | 7.90 |
| Return on Investment - 5 Yr Avg | -97.10 | 6.50 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 148,133.00 | 404,888.00 | 449,376.00 |
| Net Income/Employee (TTM) | -310,907.00 | 57,122.00 | 39,003.00 |
| Receivable Turnover (TTM) | 17.80 | 4.70 | 7.60 |
| Inventory Turnover (TTM) | n.a. | 1.70 | 8.30 |
| Asset Turnover (TTM) | 0.20 | 0.60 | 0.40 |
Portfolios with DVAX
- Portfolio NameUser Type
- Contributor10 Stocks Boosting Little F...
- UserMy stocks
- ContributorStocks Under-$10 Moving Hig...
- Contributor10 Stocks of Top-Performing...
- ContributorStocks At New 52-Week Highs...
- Contributor13 Biotech Stocks Bought an...
- Contributor10 Pharma Stocks Under $3
- Contributor4 Biotech Penny Stocks to Buy
- UserMy Portfolio
- UserStarters
Latest DVAX Headlines from TheStreet
- Dynavax Stock Gaps Down On Today's Open (DVAX) 05.09.12 | 09:05 am
- 10 Stocks Boosting Little Funds to Big Returns (Update2) 03.16.12 | 02:03 pm
- 8 Stocks Under $10 Moving Higher 02.02.12 | 02:02 pm
- 10 Stocks of Top-Performing Funds in 2012 01.20.12 | 10:01 am
- Biotech Calendar: Key Dates for October 10.03.11 | 08:10 am
- Biotech Calendar: Key Dates for September 08.31.11 | 06:08 am
- Dynavax Stock Gaps Down On Today's Open (DVAX) 07.20.11 | 09:07 am
- 10 Pharma Stocks Under $3 06.16.11 | 01:06 pm
- 4 Biotech Penny Stocks to Buy: Navellier 04.13.11 | 11:04 am
- Dynavax, Frontier Financial: Early Volume Plays 04.27.10 | 07:04 am
Press Releases for DVAX
Partner Headlines for DVAX
- Company News for May 10, 2012 - Corporate Summary - Zacks 05.10.12 | 10:05 am
- Buy And Sell Ideas Based On Monday's Big Biotech News Movers - Seeking Alpha 10.11.11 | 08:10 am
- Dynavax Reports Diabetic Subset Data From Modified Intent to Treat Analysis of the HEPLISAV Phase 3 Trial - Benzinga 10.06.11 | 04:10 pm
- 7 Breakout Stocks With Sufficient Cash to Cover Operating Expenses - Seeking Alpha 03.29.11 | 08:03 am
- Data from Dynavax for HBV Candidate - Analyst Blog - Zacks 12.27.10 | 01:12 pm
- Dynavax Announces $30 Million Common Stock Purchase (DVAX) - Benzinga 09.20.10 | 04:09 pm
- UPDATE 1-Dynavax posts Q2 loss, shares fall - Reuters 07.30.10 | 05:07 pm
- UPDATE 1-Dynavax's flu vaccine shows promise, shares rise - Reuters 04.26.10 | 05:04 pm
- Healthcare, Technology Converge: Recent Biotech Deals - SeekingAlpha.com 04.19.10 | 05:04 am
- UPDATE 1-Dynavax hep B vaccine shows promise in kidney disease - Reuters 04.14.10 | 05:04 pm
